Product Information
DICLOFENAC POT 50 MG POWDR PKT is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $10.9719 per EA under NDC 51672424006. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Jun 14, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672424006
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA218011FDA Approved
6/14/2024
TE Code
AB
On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC POT 50 MG POWDR PKT has been published 92 times since Jan 1, 2025, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.9719 per EA |
|---|---|
| All-time high | $21.6438 (Jan 15, 2025) |
| All-time low | $10.1698 (Jul 22, 2026) |
| 52-week high | $16.4363 |
| 52-week low | $10.1698 |
| Median price | $15.5267 |
| Average price | $15.4169 |
| Largest weekly change | -16.0% (Jul 22, 2026) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC POT 50 MG POWDR PKT?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC POT 50 MG POWDR PKT, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $10.9719 per EA (NDC 51672424006), effective Sep 30, 2026.
How has the price of DICLOFENAC POT 50 MG POWDR PKT changed over time?
Over the history we have for it, the NADAC for DICLOFENAC POT 50 MG POWDR PKT has declined 49.3%. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for DICLOFENAC POT 50 MG POWDR PKT?
Since Jan 1, 2025, the NADAC for DICLOFENAC POT 50 MG POWDR PKT has ranged from a low of $10.1698 (Jul 22, 2026) to a high of $21.6438 (Jan 15, 2025), with a median of $15.5267 per EA.
Are there cheaper alternatives to DICLOFENAC POT 50 MG POWDR PKT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC POT 50 MG POWDR PKT in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC POT 50 MG POWDR PKT?
DICLOFENAC POT 50 MG POWDR PKT (NDC 51672424006) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.